tosufloxacin has been researched along with Chronic Illness in 2 studies
tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a multicenter trial at 17 institutions, the usefulness of an oral dose of 300 mg of tosufloxacin (TFLX) twice a day for 14 days were assessed in the management of chronic bacterial prostatitis (CBP) diagnosed by Meares and Stamey method." | 9.07 | [Clinical studies of tosufloxacin on chronic bacterial prostatitis]. ( Hirano, A; Ikeuchi, T; Kawamura, N; Onodera, S; Osada, T; Satomi, Y; Suzuki, K; Yamamoto, Y; Yoshimura, S, 1993) |
| "Fluoroquinolones are known to cause acute renal failure because of interstitial nephritis with or without epithelioid granulomas." | 5.32 | An unusual form of crystal-forming chronic interstitial nephritis following long-term exposure to tosufloxacin tosilate. ( Ban, S; Ikeda, N; Kanno, Y; Kotaki, S; Nagata, M; Okada, H; Sugahara, S; Suzuki, H; Takane, H; Watanabe, Y, 2004) |
| "In a multicenter trial at 17 institutions, the usefulness of an oral dose of 300 mg of tosufloxacin (TFLX) twice a day for 14 days were assessed in the management of chronic bacterial prostatitis (CBP) diagnosed by Meares and Stamey method." | 5.07 | [Clinical studies of tosufloxacin on chronic bacterial prostatitis]. ( Hirano, A; Ikeuchi, T; Kawamura, N; Onodera, S; Osada, T; Satomi, Y; Suzuki, K; Yamamoto, Y; Yoshimura, S, 1993) |
| "Fluoroquinolones are known to cause acute renal failure because of interstitial nephritis with or without epithelioid granulomas." | 1.32 | An unusual form of crystal-forming chronic interstitial nephritis following long-term exposure to tosufloxacin tosilate. ( Ban, S; Ikeda, N; Kanno, Y; Kotaki, S; Nagata, M; Okada, H; Sugahara, S; Suzuki, H; Takane, H; Watanabe, Y, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okada, H | 1 |
| Watanabe, Y | 1 |
| Kotaki, S | 1 |
| Ikeda, N | 1 |
| Takane, H | 1 |
| Kanno, Y | 1 |
| Sugahara, S | 1 |
| Ban, S | 1 |
| Nagata, M | 1 |
| Suzuki, H | 1 |
| Ikeuchi, T | 1 |
| Kawamura, N | 1 |
| Suzuki, K | 1 |
| Onodera, S | 1 |
| Osada, T | 1 |
| Hirano, A | 1 |
| Satomi, Y | 1 |
| Yoshimura, S | 1 |
| Yamamoto, Y | 1 |
1 trial available for tosufloxacin and Chronic Illness
| Article | Year |
|---|---|
[Clinical studies of tosufloxacin on chronic bacterial prostatitis].
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Dru | 1993 |
1 other study available for tosufloxacin and Chronic Illness
| Article | Year |
|---|---|
An unusual form of crystal-forming chronic interstitial nephritis following long-term exposure to tosufloxacin tosilate.
Topics: Acute Kidney Injury; Chronic Disease; Fluoroquinolones; Humans; Male; Middle Aged; Naphthyridines; N | 2004 |